Last updated 2026-07-26
- Raised $25M Series A led by Bessemer Venture Partners, Dec 2025
- Raised $5.5M Seed round led by TLV Partners, Oct 2024
Total raised
$30.5M
Last: Grant 2026-06
Stage
Series A
Founded
2024
Headcount
40
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Converge Bio is aiming is revolutionize biological R&D by creating a Generative AI platform for DNA, RNA, and protein sequences.
Funding history · 2 rounds · $30.5M total
2025-12
A Round
$25.0M
★ Bessemer Venture PartnersTLV PartnersSaras CapitalVintage Investment Partners
2024-10
Seed
$5.5M
★ TLV Partners
Headcount over time
From 22 (2024-03) to 40 (2026-03) · +18 (+82%) · 9 points · source: Finder history + radar grounding
Q&A
- What is Converge Bio's primary focus?
- Converge Bio is developing a Generative AI platform for DNA, RNA, and protein sequences to revolutionize biological R&D.
- When was Converge Bio founded?
- Converge Bio was founded in May 2024.
- What was Converge Bio's most recent funding round?
- In June 2026, Converge Bio secured a Grant round of $2.5 million from the Bill & Melinda Gates Foundation.
- Which investors participated in Converge Bio's Series A round?
- In January 2026, Bessemer Venture Partners led Converge Bio's Series A round of $25 million.
- How many employees does Converge Bio currently have?
- Converge Bio has 11-50 employees.
- Who are the co-founders of Converge Bio?
- The co-founders of Converge Bio are Oded Kalev, who serves as CTO, and Dov Gertz, who serves as CEO.
- What product did Converge Bio use to improve cancer treatment?
- In May 2026, Converge Bio used its product ConvergeAB to improve a popular cancer treatment with a single prompt.
- What was the purpose of the $2.5M grant secured by Converge Bio in June 2026?
- The $2.5M grant secured by Converge Bio in June 2026 is intended to expand its fast-track AI gene discovery capabilities from pharmaceuticals to growing climate-resilient crops.
Team · 4
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Artificial IntelligenceGenerative AI
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
pharmaceuticalsbiotechnologymolecular-biologyproteins
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | converge-bio.com |
|---|---|
| linkedin.com/company/102539353 |
Identifiers & details
| Founded | 2024-5 |
|---|---|
| Employees (exact) | 40 |
Radar intelligence
Web history (Wayback)
| Domain | converge-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516949781 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2024-03-04 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | פריש דניאל 3 תל אביב - יפו |